CLARITAS PHARMACEUTICALS INC (CLAS.CA) Stock Price, Quote, News and Overview
TSX-V:CLAS - TSX Venture Exchange - CA1806342061 - Common Stock - Currency: CAD
CLAS.CA Quote, Performance and Key Statistics
TSX-V:CLAS (7/19/2022, 7:00:00 PM)
0.025
0 (-16.67%)
The current stock price of CLAS.CA is 0.025 CAD. In the past month the price decreased by -44.44%. In the past year, price decreased by -95.1%.
CLAS.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| BHC.CA | BAUSCH HEALTH COS INC | 1.5 | 2.92B | ||
| CRON.CA | CRONOS GROUP INC | 14.94 | 1.04B | ||
| TLRY.CA | TILRAY BRANDS INC | N/A | 880.42M | ||
| DHT-UN.CA | DRI HEALTHCARE TRUST | 6.63 | 783.66M | ||
| GUD.CA | KNIGHT THERAPEUTICS INC | 56.09 | 614.84M | ||
| DHT-U.CA | DRI HEALTHCARE TRUST | 4.81 | 568.88M | ||
| ACB.CA | AURORA CANNABIS INC | 123.4 | 347.06M | ||
| WEED.CA | CANOPY GROWTH CORP | N/A | 337.86M | ||
| CPH.CA | CIPHER PHARMACEUTICALS INC | 24.34 | 311.80M | ||
| NGEN.CA | NERVGEN PHARMA CORP | N/A | 247.83M | ||
| OGI.CA | ORGANIGRAM GLOBAL INC | 30.83 | 247.68M | ||
| HITI.CA | HIGH TIDE INC | N/A | 243.60M |
Related stock screener links
About CLAS.CA
Company Profile
Claritas Pharmaceuticals, Inc. engages in the development of next generation cannabinoid therapeutics. The company is headquartered in Novato, California. The company went IPO on 2005-05-19. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The firm has leased a laboratory, office, and archival space in Beverly, Massachusetts.
Company Info
CLARITAS PHARMACEUTICALS INC
41 Thunderbird Dr
Novato CALIFORNIA 94903 US
CEO: Robert E. Farrell
Employees: 0
Phone: 18888612008.0
CLARITAS PHARMACEUTICALS INC / CLAS.CA FAQ
What is the stock price of CLARITAS PHARMACEUTICALS INC today?
The current stock price of CLAS.CA is 0.025 CAD. The price decreased by -16.67% in the last trading session.
What is the ticker symbol for CLARITAS PHARMACEUTICALS INC stock?
The exchange symbol of CLARITAS PHARMACEUTICALS INC is CLAS and it is listed on the TSX Venture Exchange exchange.
On which exchange is CLAS.CA stock listed?
CLAS.CA stock is listed on the TSX Venture Exchange exchange.
What is CLARITAS PHARMACEUTICALS INC worth?
CLARITAS PHARMACEUTICALS INC (CLAS.CA) has a market capitalization of 944.66K CAD. This makes CLAS.CA a Nano Cap stock.
How many employees does CLARITAS PHARMACEUTICALS INC have?
CLARITAS PHARMACEUTICALS INC (CLAS.CA) currently has 0 employees.
Should I buy CLARITAS PHARMACEUTICALS INC (CLAS.CA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of CLAS.CA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of CLAS.CA, evaluating the profitability, health, valuation and growth aspects
- CLARITAS PHARMACEUTICALS INC (CLAS.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- CLARITAS PHARMACEUTICALS INC (CLAS.CA) Sales and EPS estimates to see what analysts future expectations are.
- CLARITAS PHARMACEUTICALS INC (CLAS.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- CLARITAS PHARMACEUTICALS INC (CLAS.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
- CLARITAS PHARMACEUTICALS INC (CLAS.CA) Stock Chart to make your own analysis
- CLARITAS PHARMACEUTICALS INC (CLAS.CA) Latest news and press-releases to stay up to date.
Does CLARITAS PHARMACEUTICALS INC (CLAS.CA) stock pay dividends?
CLAS.CA does not pay a dividend.
What is the Price/Earnings (PE) ratio of CLARITAS PHARMACEUTICALS INC (CLAS.CA)?
CLARITAS PHARMACEUTICALS INC (CLAS.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.19).
CLAS.CA Technical Analysis
CLAS.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to CLAS.CA. CLAS.CA may be in some trouble as it scores bad on both profitability and health.
CLAS.CA Financial Highlights
Over the last trailing twelve months CLAS.CA reported a non-GAAP Earnings per Share(EPS) of -0.19. The EPS decreased by -185.7% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -42.8% | ||
| ROE | N/A | ||
| Debt/Equity | 0 |
CLAS.CA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 80% to CLAS.CA. The Buy consensus is the average rating of analysts ratings from 5 analysts.